source
- Daiichi Sankyo writes off $950 million after abandoning ADC manufacturing planDaiichi Sankyo announced it will abandon its planned antibody-drug conjugate (ADC) manufacturing facility. The company said the decision follows a serious over-estimate of third-party demand for AD…
- Giants of Cancer Care Unveils 14th Annual Class of Oncology InnovatorsOncLive announced the 14th Annual Giants of Cancer Care inductees, a program that honors oncology leaders whose research, education, mentorship and patient‑focused work have reshaped cancer treatme…